Aventura Private Wealth’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Aventura Private Wealth’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-18	Closed	-$2.38K	–	850
2025 Q1	$2.38K	Hold	18	–	–	﹤0.01%	593
2024 Q4	$1.5K	Buy	+18	New	+$1.48K	﹤0.01%	606

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Aventura Private Wealth's ITCI Position: Q2 2025 in Review

Aventura Private Wealth sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 18 shares — an estimated $2.38K sold.

Aventura Private Wealth first reported a position in ITCI in Q4 2024 and held it in 2 quarters. The position peaked at $2.38K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Aventura Private Wealth reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Aventura Private Wealth sold 18 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $2.38K.
Aventura Private Wealth first reported a position in Intra-Cellular Therapies Inc. in Q4 2024 and held it in 2 quarters.
Aventura Private Wealth's Intra-Cellular Therapies Inc. position peaked at $2.38K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Aventura Private Wealth's 13F filing for Q2 2025, filed 7 Jan 2026.